Article
Chemistry, Physical
Ankitkumar Patel, Hardik Bhatt, Bhumika Patel
Summary: This study carried out 3D-QSAR research on Tankyrase inhibitors using various techniques, providing significant insights for the design of novel quinazolinone derivatives as potent inhibitors.
JOURNAL OF MOLECULAR STRUCTURE
(2022)
Article
Chemistry, Physical
Xiao Ding, Dongwei Kang, Lin Sun, Peng Zhan, Xinyong Liu
Summary: With the increasing number of AIDS patients, the search for new potent anti-HIV drugs becomes urgent. Through the analysis of CoMFA, CoMSIA, and 2D-QSAR models, insights into the design of novel anti-HIV agents can be obtained.
JOURNAL OF MOLECULAR STRUCTURE
(2022)
Article
Chemistry, Medicinal
Yuan Zhang, Juan Liu, Xin Wu, Suming Yang, Yao Li, Songbin Liu, Saifei Zhu, Xuan Cao, Zhizhong Xie, Xiaoyong Lei, Honglin Huang, Junmei Peng
Summary: The anti-chronic myeloid leukemia activity of thiazole aminobenzamide derivatives was tested in vitro using a viability assay method and was found to exhibit good inhibitory activities. Analysis using CoMFA and CoMSIA showed a relationship between the structure of these derivatives and their inhibition of leukemia cell activity, with specific substitutions improving the anti-CML activity.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2021)
Article
Biochemistry & Molecular Biology
Amina Goudzal, Abdellah El Aissouq, Hicham El Hamdani, El Ghalia Hadaji, Abdelkrim Ouammou, Mohammed Bouachrine
Summary: In this study, a 3D-QSAR analysis was performed on a series of 2, 4, 5-trisubstituted imidazole derivatives to design potent kinase II alpha subunit (CK2) inhibitors. The COMFA and COMSIA models showed excellent performance with high Q(2) and R-2 values. The validity of the models was confirmed through various validation tests. The study's findings provide useful theoretical references for future experimental studies.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2023)
Article
Chemistry, Multidisciplinary
Yunmei Liu, Zejie Tian, Hui Li, Zhenhua Liu, Lei Shi, Lingyan Yang
Summary: In this study, 3D-QSAR models were constructed to investigate the structure-activity relationship of chrysin. The structures of 54 chrysin derivatives were constructed using SYBYL-X 2.0 software, and the models were built using CoMFA and CoMSIA methods. The results showed that certain groups attached to the 7-O-alkane chain of chrysin, such as amino acids, enhance its activity, while excessively long chains or bulky hydrophobic groups reduce the activity. On the other hand, the introduction of bulky hydrophobic groups on the side chains of amino acids increases the activity of the molecule.
JOURNAL OF MATHEMATICAL CHEMISTRY
(2023)
Article
Pharmacology & Pharmacy
Yuwei Wang, Yifan Guo, Shaojia Qiang, Ruyi Jin, Zhi Li, Yuping Tang, Elaine Lai Han Leung, Hui Guo, Xiaojun Yao
Summary: In this study, the structure-activity relationships and binding modes of a series of anthraquinone derivatives targeting PGAM1 were investigated using 3D-QSAR, molecular docking, and molecular dynamics simulations, which showed satisfactory predictive ability. Molecular dynamics simulations revealed key residues and dominant interactions, as well as stable hydrogen bond formations during the ligand binding process. Overall, the study provided theoretical guidance for the design of new anthraquinone derivatives as PGAM1 inhibitors.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Food Science & Technology
Yijie Yang, Qi Tian, Shiming Li, Bo Li
Summary: In this study, 3D-QSAR analysis was performed to investigate the structure-activity relationship of collagen hydrolysate peptides. The results showed that Hyp, rather than Pro, had a greater impact on improving antiplatelet activity. The predicted peptide EOGE exhibited antiplatelet activity and inhibited thrombus formation.
Article
Chemistry, Multidisciplinary
Fangfang Wang, Wei Yang, Bo Zhou
Summary: In this study, a theoretical approach was used to investigate the structure-activity relationship and mechanism of action of novel GyrB inhibitors. The results demonstrated the stability and predictability of the CoMFA and CoMSIA models. Molecular docking and MD simulations revealed the key amino acids and binding modes at the active site. These findings provide valuable guidance for the discovery and design of new GyrB inhibitors.
ARABIAN JOURNAL OF CHEMISTRY
(2022)
Article
Chemistry, Multidisciplinary
Fangfang Wang, Wei Yang, Ran Li, Zhihai Sui, Guijuan Cheng, Bo Zhou
Summary: Through 3D-QSAR and molecular dynamics simulations, the structure-activity relationships and mechanism of actions of FAK inhibitors were investigated, predicting the inhibitory activities of novel inhibitors and guiding the optimization of FAK inhibitors with higher inhibitory activities.
ARABIAN JOURNAL OF CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Fangfang Wang, Yingchao Qiu, Bo Zhou
Summary: This study utilized 3D-QSAR, molecular docking, and molecular dynamics simulations to investigate the structure-activity relationship of HO-PCBs towards ERβ for the first time. The results revealed important structural features and interactions, providing a better understanding of the specific mechanism of HO-PCBs on ERβ.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2022)
Article
Biochemistry & Molecular Biology
Keerti Vishwakarma, Hardik Bhatt
Summary: This study focuses on the design of novel telomerase inhibitors using various methods, including ligand-based and structure-based approaches. In-depth experimental research was conducted using 3D-QSAR, molecular docking, and molecular dynamics simulation, with results suggesting the potential for developing potent telomerase inhibitors.
JOURNAL OF MOLECULAR MODELING
(2021)
Article
Biochemistry & Molecular Biology
Qinghua Chen, Fangfang Wang, Bo Zhou
Summary: In this study, various ROR gamma t agonists were investigated using multiple molecular modeling techniques to understand the structural requirements for designing better active compounds. The CoMFA and CoMSIA models showed satisfactory predictive ability, while molecular docking and dynamics simulations identified key residues for higher binding activity in the active site of ROR gamma t.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2021)
Article
Biochemistry & Molecular Biology
Swapnil P. Bhujbal, Jung-Mi Hah
Summary: Radiotherapy and chemotherapy are standard cancer treatments used in combination with surgery for around 60% of cancer patients. Only a few patients respond to immune checkpoint blockage due to low tumor immunogenicity, with tumor cells often evading immune surveillance through CD73 signaling and extracellular adenosine production. In this study, non-nucleotide small molecule inhibitors targeting CD73 were designed using molecular docking and 3D-QSAR studies, showing promising activity compared to existing compounds. Further experimental validation of these new inhibitors is required.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Chemistry, Inorganic & Nuclear
Chen Xiao-Zhong, Li Guang-Ping, Shen Yan, Hu Yong, Wang Juan, Wang Yuan-Qiang, Lin Zhi-Hua
Summary: This study utilized 3D-QSAR and molecular docking to investigate a series of EED inhibitors, establishing robust and predictive models, designing five new small molecules, and evaluating their ADME properties, providing theoretical guidance for the rational design of novel EED inhibitors.
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Fangfang Wang, Wei Yang, Hongping Liu, Bo Zhou
Summary: The molecular modeling study on quinazoline derivatives as EGFR inhibitors revealed reliable and satisfactory models with structural features to improve inhibitory activity. Hydrogen bond, hydrophobic, and electrostatic interactions play significant roles on activity and selectivity, while specific amino acid residues participate in ligand-receptor interactions.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
(2022)
Article
Chemistry, Medicinal
Mousumi Shyam, Harshita Verma, Gourab Bhattacharje, Piyali Mukherjee, Samsher Singh, Sujit Kamilya, Pushpendu Jalani, Swetarka Das, Arunava Dasgupta, Abhishake Mondal, Amit Kumar Das, Amit Singh, Federico Brucoli, Claire Bagneris, Rachael Dickman, Vinay N. Basavanakatti, Patibandla Naresh Babu, Vadivelan Sankaran, Abhimanyu Dev, Barij Nayan Sinha, Sanjib Bhakta, Venkatesan Jayaprakash
Summary: In this study, pyrazoline analogues were designed and synthesized to mimic the structure of Mycobactin. Compounds 44 and 49 were identified as potential mycobactin biosynthesis inhibitors against mycobacteria, demonstrating effective eradication of intracellular mycobacteria. These compounds also showed stronger efflux pump inhibition compared to known inhibitors. This study provides a new strategy for combating antimicrobial resistance challenges.
JOURNAL OF MEDICINAL CHEMISTRY
(2022)
Review
Chemistry, Medicinal
Sheikh Murtuja, Deepak Shilkar, Biswatrish Sarkar, Barij Nayan Sinha, Venkatesan Jayaprakash
Summary: This article provides a detailed analysis of each case of design and development of peptide inhibitors against DENV NS2B-NS3 protease in the past two decades. The reasons for their inhibitory activity are discussed, and suggestions to improve the inhibitory activity are highlighted whenever possible.
MINI-REVIEWS IN MEDICINAL CHEMISTRY
(2022)
Review
Cardiac & Cardiovascular Systems
Amrita Chatterjee, Rajdeep Saha, Arpita Mishra, Deepak Shilkar, Venkatesan Jayaprakash, Pawan Sharma, Biswatrish Sarkar
Summary: Since 2019, the novel coronavirus SARS-CoV-2 has caused an unprecedented pandemic worldwide. It has led to significant damage to multiple organs, including the lungs and heart. The disease is complicated by cardiovascular injury, hypoxia-induced myocardial injury, and systemic inflammatory responses. This review examines the impact of COVID-19 on cardiovascular health, comorbidities, and post-immunization cardiovascular complications.
CURRENT PROBLEMS IN CARDIOLOGY
(2023)
Review
Pharmacology & Pharmacy
Mousumi Shyam, Deepak Shilkar, Gourav Rakshit, Venkatesan Jayaprakash
Summary: This article discusses the opportunities to develop new drugs and prolong the shelf life of existing therapeutics by targeting the conditionally essential pathways inside Mycobacterium. The article emphasizes the bottlenecks in fast-tracking antitubercular drug discovery and proposes some strategies for new drug development.
EXPERT OPINION ON DRUG DISCOVERY
(2022)
Article
Biochemistry & Molecular Biology
Hatice Yildirim, Nilufer Bayrak, Mahmut Yildiz, Fatima Nur Yilmaz, Emel Mataraci-Kara, Deepak Shilkar, Venkatesan Jayaprakash, Amac Fatih TuYuN
Summary: Two subseries of aminated quinolinequinones (AQQs) were successfully synthesized, with electron-withdrawing group or electron-donating group in aryl amine moiety. The AQQs with an electron-donating group exhibited strong antibacterial activity against Gram-positive bacterial strains, while the AQQ with an electron-withdrawing group displayed excellent antifungal activity against Candida albicans. In vitro and in silico studies were conducted to explore the mode of action of the selected AQQs.
Article
Chemistry, Multidisciplinary
Shipra Bhatt, Sumit Dhiman, Vinay Kumar, Abhishek Gour, Diksha Manhas, Kuhu Sharma, Probir Kumar Ojha, Utpal Nandi
Summary: Pinocembrin, a potential drug candidate for neurodegenerative diseases, has been found to have a potent inhibitory action on CYP1A2, an enzyme responsible for xenobiotic metabolism. In vitro and in silico studies demonstrate the strong interaction between pinocembrin and CYP1A2, and in vivo investigations using a rat model confirm its potential to cause drug interactions. Further clinical studies are warranted to confirm these findings.
Article
Chemistry, Multidisciplinary
Shipra Bhatt, Diksha Manhas, Vinay Kumar, Abhishek Gour, Kuhu Sharma, Ashish Dogra, Probir Kumar Ojha, Utpal Nandi
Summary: Myricetin, a bioflavonoid, has shown potent inhibitory effects on CYP2C8 enzyme and may cause drug interactions at the hepatic level. The study suggests that further exploration is needed to avoid adverse effects and optimize anticancer therapy.
Article
Chemistry, Physical
Abhishek Thakur, Gaurav Sharma, Vishnu Nayak Badavath, Venkatesan Jayaprakash, Kenneth M. Merz, Galia Blum, Orlando Acevedo
Summary: The COVID-19 outbreak has caused massive devastation worldwide, with millions of infections and deaths reported. Using a combination of crystal structures and validated inhibitors, four rules for designing potent inhibitors of SARS-CoV-2 main protease have been proposed. Experimental examination identified a potential lead compound with higher potency than known inhibitors.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS
(2022)
Article
Chemistry, Multidisciplinary
Gourav Rakshit, Venkatesan Jayaprakash
Summary: This study investigated the potential of a reported antitubercular molecule as an inhibitor for HIV-1 and nCOVID-19, leading to the discovery of a multi-targeted inhibitor for triple co-infections. The results showed strong binding of the molecule to the target proteins, as well as stability throughout the simulation. In silico ADMET results also indicated satisfactory pharmacokinetic properties. Overall, this computational study identified a potential molecule for further exploration and development of inhibitors against triple infections.
STRUCTURAL CHEMISTRY
(2023)
Article
Chemistry, Medicinal
Ayse Tarbin Jannuzzi, Ayse Mine Yilmaz Goler, Nilufer Bayrak, Mahmut Yildiz, Hatice Yildirim, Betul Karademir Yilmaz, Deepak Shilkar, Raghusrinivasan Jayaprakash Venkatesan, Venkatesan Jayaprakash, Amac Fatih TuYuN
Summary: Using plastoquinone analogs as lead structures, the investigation of brominated PQ analogs in multiple cancer cell lines has revealed significant growth inhibition effects. These analogs exhibit favorable drug-like properties and have the potential to interact with proteasome catalytic subunits. In vitro assays have shown that brominated PQ analogs induce cytotoxicity by causing cell cycle arrest and oxidative stress. These findings offer valuable insights for the development of novel antiproliferative agents.
Article
Chemistry, Medicinal
Venkatesan Jayaprakash, Thangavelu Saravanan, Karuppaiyan Ravindran, Thangavelu Prabha, Jubie Selvaraj, Sudeepan Jayapalan, M. V. N. L. Chaitanya, Thangavel Sivakumar
Summary: In this study, a new open-source data analysis Python script was used to discover lead compounds for anticancer drugs by building a QSAR model using 53 thiazole derivatives. Machine learning approaches were employed, and the performance of the model was evaluated using three different algorithms.
CURRENT COMPUTER-AIDED DRUG DESIGN
(2023)
Article
Chemistry, Multidisciplinary
Hatice Yildirim, Nilufer Bayrak, Mahmut Yildiz, Emel Mataraci-Kara, Serol Korkmaz, Deepak Shilkar, Venkatesan Jayaprakash, Amac Faith Tuyun
Summary: This study identified aminated quinolinequinones as potential candidates for novel antibacterial and/or antifungal agents. Some of the compounds demonstrated antimicrobial activity against selected bacterial and fungal strains. AQQ6 and AQQ9 were active against Enterococcus faecalis, while AQQ8 and AQQ9 showed activity against Staphylococcus aureus. AQQ8 and AQQ9 were identified as promising lead molecules for further exploration of their mode of action and antimicrobial activity against biofilm-forming microbes.
Article
Chemistry, Medicinal
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
Summary: A new ligand 10 was identified, which can potently activate both PPAR alpha and -gamma subtypes as full and partial agonists, respectively. Docking studies were performed to explain the different effects on the two targets. In vivo experiments showed that compound 10 significantly reduced blood glucose and lipid levels in diabetic mouse models without toxic effects, and further investigation revealed its inhibitory effect on the mitochondrial pyruvate carrier, suggesting its potential for treating dyslipidemic type 2 diabetes as a new class of drugs.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Biochemistry & Molecular Biology
Deepak Shilkar, Mohd Usman Mohd Siddique, Silvia Bua, Sabina Yasmin, Mrunali Patil, Ajay Kumar Timiri, Claudiu T. Supuran, Venkatesan Jayaprakash
Summary: A series of phthalimide-capped benzene sulphonamides (1-22) were evaluated for their inhibitory activity against carbonic anhydrase I (hCA I) and carbonic anhydrase II (hCA II). Compound 1 showed potent inhibitory activity against both hCA I (Ki = 28.5 nM) and hCA II (Ki = 2.2 nM), with 10 and 6 times higher potency than the standard inhibitor, acetazolamide. Molecular docking and MD simulations were performed to understand the atomic level interactions responsible for the selectivity of compound 1 towards hCA II.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
(2023)
Article
Multidisciplinary Sciences
Sayanti Halder, Abhishek Thakur, Supriya Suman Keshry, Pradip Jana, Divyanshi Karothia, Indrani Das Jana, Orlando Acevedo, Rajeeb K. Swain, Arindam Mondal, Soma Chattopadhyay, Venkatesan Jayaprakash, Abhimanyu Dev
Summary: The article introduces an aptamer-based system with diagnostic and therapeutic potential against COVID-19. Aptamer R is shown to specifically inhibit the entry of SARS-CoV-2 virus, and its antiviral potential is tested and analyzed. The study also investigates the intermolecular interactions between the aptamers and the virus domain.
SCIENTIFIC REPORTS
(2023)
Article
Chemistry, Medicinal
Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang
Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon
Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai
Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang
Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho
Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski
Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun
Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan
Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)
Article
Chemistry, Medicinal
Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang
Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2024)